81 related articles for article (PubMed ID: 8929631)
1. Ultrastructural features and P-glycoprotein immunolocalization in Saos-2/DX580 multidrug-resistant human osteosarcoma cells.
Maraldi NM; Zini N; Sabatelli P; Valmori A; Scotlandi K; Serra M; Baldini N
J Submicrosc Cytol Pathol; 1996 Jan; 28(1):93-100. PubMed ID: 8929631
[TBL] [Abstract][Full Text] [Related]
2. Nuclear immunolocalization of P-glycoprotein in multidrug-resistant cell lines showing similar mechanisms of doxorubicin distribution.
Baldini N; Scotlandi K; Serra M; Shikita T; Zini N; Ognibene A; Santi S; Ferracini R; Maraldi NM
Eur J Cell Biol; 1995 Nov; 68(3):226-39. PubMed ID: 8603675
[TBL] [Abstract][Full Text] [Related]
3. P-glycoprotein subcellular localization and cell morphotype in MDR1 gene-transfected human osteosarcoma cells.
Maraldi NM; Zini N; Santi S; Scotlandi K; Serra M; Baldini N
Biol Cell; 1999 Jan; 91(1):17-28. PubMed ID: 10321019
[TBL] [Abstract][Full Text] [Related]
4. Immunocytochemical observation of multidrug resistance (MDR) p170 glycoprotein expression in human osteosarcoma cells. The clinical significance of MDR protein overexpression.
Bodey B; Taylor CR; Siegel SE; Kaiser HE
Anticancer Res; 1995; 15(6B):2461-8. PubMed ID: 8669809
[TBL] [Abstract][Full Text] [Related]
5. Multidrug resistance and malignancy in human osteosarcoma.
Scotlandi K; Serra M; Nicoletti G; Vaccari M; Manara MC; Nini G; Landuzzi L; Colacci A; Bacci G; Bertoni F; Picci P; Campanacci M; Baldini N
Cancer Res; 1996 May; 56(10):2434-9. PubMed ID: 8625324
[TBL] [Abstract][Full Text] [Related]
6. Evidence for cytoplasmic P-glycoprotein location associated with increased multidrug resistance and resistance to chemosensitizers.
Abbaszadegan MR; Cress AE; Futscher BW; Bellamy WT; Dalton WS
Cancer Res; 1996 Dec; 56(23):5435-42. PubMed ID: 8968098
[TBL] [Abstract][Full Text] [Related]
7. Increase of nuclear phosphatidylinositol 4,5-bisphosphate and phospholipase C beta 1 is not associated to variations of protein kinase C in multidrug-resistant Saos-2 cells.
Zini N; Neri LM; Ognibene A; Scotlandi K; Baldini N; Maraldi NM
Microsc Res Tech; 1997 Feb; 36(3):172-8. PubMed ID: 9080407
[TBL] [Abstract][Full Text] [Related]
8. Differentially expressed genes in multidrug resistant variants of U-2 OS human osteosarcoma cells.
Chano T; Mori K; Scotlandi K; Benini S; Lapucci C; Manara MC; Serra M; Picci P; Okabe H; Baldini N
Oncol Rep; 2004 Jun; 11(6):1257-63. PubMed ID: 15138564
[TBL] [Abstract][Full Text] [Related]
9. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
[TBL] [Abstract][Full Text] [Related]
10. Establishment and characterization of multidrug-resistant human osteosarcoma cell lines.
Serra M; Scotlandi K; Manara MC; Maurici D; Lollini PL; De Giovanni C; Toffoli G; Baldini N
Anticancer Res; 1993; 13(2):323-9. PubMed ID: 8100126
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of Type I interferons in the treatment of multidrug resistant osteosarcoma cells.
Manara MC; Serra M; Benini S; Picci P; Scotlandi K
Int J Oncol; 2004 Feb; 24(2):365-72. PubMed ID: 14719113
[TBL] [Abstract][Full Text] [Related]
12. Voacamine, an alkaloid extracted from Peschiera fuchsiaefolia, inhibits P-glycoprotein action in multidrug-resistant tumor cells.
Meschini S; Marra M; Condello M; Calcabrini A; Federici E; Dupuis ML; Cianfriglia M; Arancia G
Int J Oncol; 2005 Dec; 27(6):1597-603. PubMed ID: 16273216
[TBL] [Abstract][Full Text] [Related]
13. Drug resistance modification using pulsing electromagnetic field stimulation for multidrug resistant mouse osteosarcoma cell line.
Hirata M; Kusuzaki K; Takeshita H; Hashiguchi S; Hirasawa Y; Ashihara T
Anticancer Res; 2001; 21(1A):317-20. PubMed ID: 11299755
[TBL] [Abstract][Full Text] [Related]
14. P-glycoprotein, expressed in multidrug resistant cells, is not responsible for alterations in membrane fluidity or membrane potential.
Alemán C; Annereau JP; Liang XJ; Cardarelli CO; Taylor B; Yin JJ; Aszalos A; Gottesman MM
Cancer Res; 2003 Jun; 63(12):3084-91. PubMed ID: 12810633
[TBL] [Abstract][Full Text] [Related]
15. Ultrastructural changes related to multidrug resistance in CEM cells: role of cytoplasmic vesicles in drug exclusion.
Bobichon H; Colin M; Depierreux C; Liautaud-Roger F; Jardillier JC
J Exp Ther Oncol; 1996 Jan; 1(1):49-61. PubMed ID: 9414388
[TBL] [Abstract][Full Text] [Related]
16. The nuclear membrane in multidrug resistance: microinjection of epirubicin into bladder cancer cell lines.
Featherstone JM; Speers AG; Lwaleed BA; Hayes MC; Cooper AJ; Birch BR
BJU Int; 2005 May; 95(7):1091-8. PubMed ID: 15839939
[TBL] [Abstract][Full Text] [Related]
17. Osteoblastic differentiation and P-glycoprotein multidrug resistance in a murine osteosarcoma model.
Takeshita H; Kusuzaki K; Murata H; Suginoshita T; Hirata M; Hashiguchi S; Ashihara T; Gebhardt MC; Mankin HJ; Hirasawa Y
Br J Cancer; 2000 Apr; 82(7):1327-31. PubMed ID: 10755409
[TBL] [Abstract][Full Text] [Related]
18. P-glycoprotein, multidrug resistance and protein kinase C.
Fine RL; Chambers TC; Sachs CW
Stem Cells; 1996 Jan; 14(1):47-55. PubMed ID: 8820951
[TBL] [Abstract][Full Text] [Related]
19. Intracellular P-glycoprotein in multidrug resistant tumor cells.
Arancia G; Molinari A; Calcabrini A; Meschini S; Cianfriglia M
Ital J Anat Embryol; 2001; 106(2 Suppl 1):59-68. PubMed ID: 11729998
[TBL] [Abstract][Full Text] [Related]
20. Multidrug resistance mediated by overexpression of P-glycoprotein in human osteosarcoma in vivo.
Suto R; Abe Y; Nakamura M; Ohnishi Y; Yoshimura M; Lee YH; Imanishi T; Yamazaki H; Kijima H; Tokunaga T; Oshika Y; Hiraoka N; Tamaoki N; Fukuda H; Ueyama Y
Int J Oncol; 1998 Feb; 12(2):287-91. PubMed ID: 9458350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
